Synonyms: Sch 717454
Robatumumab (Anti-IGF1R / CD221) is an antibody targeting human IGF-1R (insulin-like growth factor receptor-1). It shows anti-tumor activity and anti-proliferative activity to cancer cells and can be used in osteosarcoma and Ewing sarcoma research. MW :144.6 KD
| Featured Inhibitors | Y-27632 Dihydrochloride SB431542 CHIR-99021 (Laduviglusib) RMC-7977 RMC-6236 (Daraxonrasib) MRTX1133 MG132 Z-VAD-FMK VT3989 IAG933 |
|---|
| Name | Citation | IGF-1R | Insulin Receptor | Others |
|---|---|---|---|---|
| Linsitinib (OSI-906) | 206 | IRR | ||
| NVP-AEW541 | 65 | FLT3,Tek,FLT1 | ||
| GSK1904529A | 26 | |||
| NVP-ADW742 | 24 | |||
| BMS-536924 | 26 | FAK,MEK,LCK | ||
| AG-1024 | 27 | |||
| GSK1838705A | 18 | ALK | ||
| BMS-754807 | 54 | TrkB,Met,TrkA | ||
| PQ 401 | 3 | |||
| Ginsenoside Rg5 | 0 | |||
| XL228 | 0 | ABL T315I,LYN,Aurora A | ||
| Picropodophyllin (AXL1717) | 48 | |||
| AZD3463 | 7 | ALK | ||
| S961 | 3 | |||
| Nordihydroguaiaretic acid (NDGA) | 1 | p300,HER2,lipoxygenase |
| Description |
Robatumumab (Anti-IGF1R / CD221) is an antibody targeting human IGF-1R (insulin-like growth factor receptor-1). It shows anti-tumor activity and anti-proliferative activity to cancer cells and can be used in osteosarcoma and Ewing sarcoma research. MW :144.6 KD
|
References |
|---|
| CAS No. | 934235-44-6 |
|---|---|
| Isotype | Human IgG1 |
| Source | CHO |
| Formulation | 100 mM Pro-Ac, 20mM Arg, pH5.0 |
| Storage (From the date of receipt) |
Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles. |
*Literature analysis of various clone (for this target) products available on the market shows that Selleck's selected clones are more frequently applied. (data until September 2024)
Tel: +1-832-582-8158 Ext:3
If you have any other enquiries, please leave a message.